IDH1 and central nervous system cancer: Patients with MGMT promoter methylation and IDH1 mutation are associated with increased progression-free and overall survival.[42, 43] Here, by performing multivariable Cox regression analysis, we showed that the radiosensitivity gene signature is independent of these possible prognostic predictors(when available) among patients of glioma treated with radiotherapy.